Delivery Order SPE2DB24D1205-SPE2DB25FCXMK
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of AYVAKIT 300 mg tablets (30-count) with a ceiling value of $24,675.50. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a pediatric cancer medication delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of AYVAKIT 200 mg tablets (30-count units) with a ceiling value of $24,403.80. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award utilized no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive delivery order executed by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of AYVAKIT 25 MG tablets (30-count units) with a ceiling value of $73,106.76. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ayvakit 25 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $48,737.84, represents a non-set-aside competitive award and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count units) on September 16, 2025, with a ceiling value of $48,737.84 and completion date of October 7, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The performance location is...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for the supply of the drug AYVAKIT 25 MG TABLET 30S. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXMKDelivery Order
The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count package. The contract, with an ultimate completion date of June 30, 2025, represents a non-competitive, non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order falls under AmerisourceBergen's substantial IDC with DLA valued at $999,999,999.00 and extending through December 2026, which functions as a global pharmaceutical support vehicle enabling the company to supply medications across multiple therapeutic domains to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the DLA's medical supply chain infrastructure. As a child contract under the larger IDC framework, this order demonstrates the company's ongoing capability to fulfill federal pharmaceutical procurement requirements for specialty medications in support of military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 6/6/25 |